TidemaxxingTidemaxxing
CJC-1295 with DAC
Growth

Buy CJC-1295 with DAC — 10 mg Lyophilized Vial

≥98% HPLC purity · lot-matched CoA · sealed under nitrogen

Structured around IGF-1 downstream phosphorylation — hypertrophy-model research.

CJC-1295 is a growth-hormone-releasing hormone (GHRH) analog engineered for extended stability. Two variants dominate the research literature: CJC-1295 "No DAC" — a shorter-acting GHRH analog — and CJC-1295 "with DAC" — which includes a Drug Affinity Complex that binds albumin and dramatically extends circulating half-life.

$89.99$99.99SAVE 10%
USD · ships lyophilized · discount auto-applied
Buy CJC-1295 with DAC now →
growthperformancesecretagogue
Bac-water math

Reconstitution volumes

Volumes of bacteriostatic water required to dissolve each vial at common research concentrations.

Vialat 2 mg/mLat 5 mg/mLat 10 mg/mL
10 mg5 mL2 mL1 mL

Numbers are calculated from the stated vial mass. Verify against the supplier's instructions for your specific research protocol.

At a glance

Key facts

  • Two research variants: No DAC (short-acting) and with DAC (long-acting)
  • GHRH analog — different receptor than ghrelin-pathway secretagogues
  • Frequently paired with ipamorelin for dual-pathway GH research
  • Well-documented pharmacokinetic profiles in both variants
Primer

Mechanism in the literature

Both variants bind the GHRH receptor in the anterior pituitary, stimulating growth-hormone release. The "with DAC" version carries a lysine-reactive maleimide linker that covalently binds serum albumin, extending half-life from hours (No DAC) to days (with DAC).

From the same shelf

Often paired with

Buyers viewing CJC-1295 with DAC typically also consider GHRP-2, Gonadorelin Acetate and Sermorelin. Each is in stock, sealed under nitrogen with a lot-matched CoA.

What it's used for

Research use-cases

  • Two research variants: No DAC (short-acting) and with DAC (long-acting)
  • GHRH analog — different receptor than ghrelin-pathway secretagogues
  • Frequently paired with ipamorelin for dual-pathway GH research
  • Well-documented pharmacokinetic profiles in both variants
Protocol notes

Handling in the lab

No DAC protocols typically use multi-daily dosing to match natural GH pulsatility. With DAC protocols use once-weekly schedules due to the extended half-life. Reconstitute in BAC water and aliquot.

Pairing notes

Stacking and paired-compound work

CJC-1295 + Ipamorelin is the standard dual-pathway GH research combination. Tesamorelin is an alternative GHRH-analog for researchers who prefer not to work with DAC-linked compounds.

Storage and shelf-life

Lyophilized powder is stable at ambient shipping temperatures. Once reconstituted with bacteriostatic water, store at 2–8 °C and use within 28 days. For long-term storage of unreconstituted vials, freeze at −20 °C and protect from light.

Questions we get

Frequently asked

What does "DAC" mean?

Drug Affinity Complex — a chemical modification that allows the peptide to covalently bind serum albumin, extending its circulating half-life from hours to days.

Should I choose DAC or No DAC?

Depends on protocol design. No DAC is used when mimicking natural pulsatile GH release; with DAC is used for sustained-level research where weekly dosing is preferable.

How does it differ from ipamorelin?

CJC-1295 is a GHRH analog. Ipamorelin is a ghrelin-receptor agonist. They work on different receptors and are often combined.

Is it stable long-term?

Unreconstituted vials are stable at −20 °C for extended periods. Reconstituted solutions follow standard peptide handling — 2–8 °C, 28 days.

More Growth compounds

Related reading